Rather than attempting to re-inject, patients should follow the missed dose guidance in the Patient Information Leaflet: if within 5 days of the scheduled dose, take it as soon as possible
References include Jastreboff et al., New England Journal of Medicine , 2022 (SURMOUNT-1, tirzepatide for obesity), the FDA Zepbound prescribing information, the FDA Drug Shortages list (accessed Q1 2026), Patel et al., Annals of Pharmacotherapy , 2024 (compounded GLP-1 dosing errors), and the U.S
B.YassourM.SaukJ.GarnerA.JiangX.ArthurT.et al
Topical peptides have been well-studied and have an established safety profile because they act primarily at the skins surface and have minimal systemic exposure
How Much Extra Weight Loss Does Bupropion Add
4 Colorado Department of Health Care Policy and Financing